Operating Income (Loss) in USD of IGC Pharma, Inc. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IGC Pharma, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • IGC Pharma, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$2.9M, a 64.7% decline year-over-year.
  • IGC Pharma, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$8.09M, a 13.2% increase year-over-year.
  • IGC Pharma, Inc. annual Operating Income (Loss) for 2024 was -$7.45M, a 24% increase from 2023.
  • IGC Pharma, Inc. annual Operating Income (Loss) for 2023 was -$9.8M, a 15.3% increase from 2022.
  • IGC Pharma, Inc. annual Operating Income (Loss) for 2022 was -$11.6M, a 25% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

IGC Pharma, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$8.09M -$2.9M -$1.14M -64.7% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$6.96M -$1.91M +$491K +20.5% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$7.45M -$1.41M +$758K +34.9% 01 Jan 2025 31 Mar 2025 10-K 27 Jun 2025
Q4 2024 -$8.2M -$1.88M +$1.12M +37.4% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 -$9.32M -$1.76M +$731K +29.3% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 -$10.1M -$2.4M -$257K -12% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$9.8M -$2.17M +$1.83M +45.8% 01 Jan 2024 31 Mar 2024 10-K 27 Jun 2025
Q4 2023 -$11.6M -$3M -$720K -31.6% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025
Q3 2023 -$10.9M -$2.49M -$3K -0.12% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 -$10.9M -$2.14M +$663K +23.7% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 -$11.6M -$4M +$2.5M +38.4% 01 Jan 2023 31 Mar 2023 10-K 24 Jun 2024
Q4 2022 -$14.1M -$2.28M +$107K +4.49% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024
Q3 2022 -$14.2M -$2.49M +$1.86M +42.8% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$16M -$2.8M -$608K -27.7% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$15.4M -$6.5M -$3.71M -133% 01 Jan 2022 31 Mar 2022 10-K 07 Jul 2023
Q4 2021 -$11.7M -$2.39M -$59K -2.54% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023
Q3 2021 -$11.7M -$4.35M -$2.67M -159% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 -$8.99M -$2.19M -$263K -13.6% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022
Q1 2021 -$8.72M -$2.79M -$348K -14.2% 01 Jan 2021 31 Mar 2021 10-K 23 Jun 2022
Q4 2020 -$8.38M -$2.33M -$648K -38.6% 01 Oct 2020 31 Dec 2020 10-Q 10 Feb 2022
Q3 2020 -$7.73M -$1.68M -$388K -30.1% 01 Jul 2020 30 Sep 2020 10-Q 29 Oct 2021
Q2 2020 -$7.34M -$1.93M -$476K -32.7% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021
Q1 2020 -$6.86M -$2.44M -$744K -43.8% 01 Jan 2020 31 Mar 2020 10-K 14 Jun 2021
Q4 2019 -$6.12M -$1.68M -$100K -6.34% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021
Q3 2019 -$6.02M -$1.29M -$433K -50.6% 01 Jul 2019 30 Sep 2019 10-Q 20 Nov 2020
Q2 2019 -$5.59M -$1.46M -$944K -185% 01 Apr 2019 30 Jun 2019 10-Q 19 Aug 2020
Q1 2019 -$4.64M -$1.7M -$1.04M -159% 01 Jan 2019 31 Mar 2019 10-K 13 Jul 2020
Q4 2018 -$3.6M -$1.58M -$1.11M -234% 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020
Q3 2018 -$2.5M -$855K -$592K -225% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 -$1.9M -$511K -$115K -29% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 -$1.79M -$657K +$143K +17.9% 01 Jan 2018 31 Mar 2018 10-K 14 Jun 2019
Q4 2017 -$1.93M -$473K -$86.9K -22.5% 01 Oct 2017 31 Dec 2017 10-Q 12 Feb 2019
Q3 2017 -$1.85M -$263K +$287K +52.2% 01 Jul 2017 30 Sep 2017 10-Q 16 Oct 2018
Q2 2017 -$2.13M -$396K -$77.5K -24.3% 01 Apr 2017 30 Jun 2017 10-Q 03 Aug 2018
Q1 2017 -$2.05M -$800K +$965K +54.7% 01 Jan 2017 31 Mar 2017 10-K 21 Jun 2018
Q4 2016 -$3.02M -$386K -$11.1K -2.96% 01 Oct 2016 31 Dec 2016 10-Q 20 Feb 2018
Q3 2016 -$3.01M -$550K -$41.4K -8.15% 01 Jul 2016 30 Sep 2016 10-Q 17 Nov 2017
Q2 2016 -$2.97M -$319K -$61.5K -23.9% 01 Apr 2016 30 Jun 2016 10-Q 18 Aug 2017
Q1 2016 -$2.91M -$1.77M +$163K +8.44% 01 Jan 2016 31 Mar 2016 10-K 14 Jul 2017
Q4 2015 -$3.07M -$375K +$124K +24.9% 01 Oct 2015 31 Dec 2015 10-Q 21 Feb 2017
Q3 2015 -$3.19M -$508K +$257K +33.6% 01 Jul 2015 30 Sep 2015 10-Q 21 Nov 2016
Q2 2015 -$3.45M -$257K +$893K +77.6% 01 Apr 2015 30 Jun 2015 10-Q 16 Aug 2016
Q1 2015 -$4.34M -$1.93M -$388K -25.2% 01 Jan 2015 31 Mar 2015 10-K 14 Jul 2016
Q4 2014 -$3.95M -$499K -$205K -69.8% 01 Oct 2014 31 Dec 2014 10-Q 16 Feb 2016
Q3 2014 -$3.75M -$765K -$333K -76.9% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$3.42M -$1.15M -$889K -341% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$2.53M -$1.54M +$861K +35.9% 01 Jan 2014 31 Mar 2014 10-K 14 Jul 2015
Q4 2013 -$3.39M -$294K -$749K -165% 01 Oct 2013 31 Dec 2013 10-Q 12 Feb 2015
Q3 2013 -$2.64M -$433K -$88.9K -25.9% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$2.55M -$261K -$66.6K -34.3% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 -$2.48M -$2.4M +$2.64M +52.4% 01 Jan 2013 31 Mar 2013 10-K 15 Jul 2014
Q4 2012 -$5.13M $455K +$1.5M 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014
Q3 2012 -$6.63M -$344K +$376K +52.2% 01 Jul 2012 30 Sep 2012 10-Q 08 Nov 2013
Q2 2012 -$7.01M -$194K +$504K +72.2% 01 Apr 2012 30 Jun 2012 10-Q 16 Aug 2013
Q1 2012 -$7.51M -$5.04M +$8.02M +61.4% 01 Jan 2012 31 Mar 2012 10-K 15 Jul 2014
Q4 2011 -$15.5M -$1.05M +$441K +29.6% 01 Oct 2011 31 Dec 2011 10-Q 13 Feb 2013
Q3 2011 -$16M -$719K +$76.4K +9.6% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 -$16.1M -$698K -$166K -31.2% 01 Apr 2011 30 Jun 2011 10-Q/A 21 Aug 2012
Q1 2011 -$15.9M -$13.1M 01 Jan 2011 31 Mar 2011 10-K 16 Jul 2012
Q4 2010 -$1.49M 01 Oct 2010 31 Dec 2010 10-Q 16 Feb 2012
Q3 2010 -$796K 01 Jul 2010 30 Sep 2010 10-Q 18 Nov 2011
Q2 2010 -$532K 01 Apr 2010 30 Jun 2010 10-Q 18 Aug 2011

IGC Pharma, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7.45M +$2.35M +24% 01 Apr 2024 31 Mar 2025 10-K 27 Jun 2025
2023 -$9.8M +$1.77M +15.3% 01 Apr 2023 31 Mar 2024 10-K 27 Jun 2025
2022 -$11.6M +$3.86M +25% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024
2021 -$15.4M -$6.7M -76.8% 01 Apr 2021 31 Mar 2022 10-K 07 Jul 2023
2020 -$8.72M -$1.86M -27.1% 01 Apr 2020 31 Mar 2021 10-K 23 Jun 2022
2019 -$6.86M -$2.22M -47.8% 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021
2018 -$4.64M -$2.85M -160% 01 Apr 2018 31 Mar 2019 10-K 13 Jul 2020
2017 -$1.79M +$265K +12.9% 01 Apr 2017 31 Mar 2018 10-K 14 Jun 2019
2016 -$2.05M +$851K +29.3% 01 Apr 2016 31 Mar 2017 10-K 21 Jun 2018
2015 -$2.91M +$1.44M +33.1% 01 Apr 2015 31 Mar 2016 10-K 14 Jul 2017
2014 -$4.34M -$1.81M -71.8% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016
2013 -$2.53M -$44.1K -1.78% 01 Apr 2013 31 Mar 2014 10-K 14 Jul 2015
2012 -$2.48M +$5.03M +66.9% 01 Apr 2012 31 Mar 2013 10-K 15 Jul 2014
2011 -$7.51M +$8.37M +52.7% 01 Apr 2011 31 Mar 2012 10-K 15 Jul 2014
2010 -$15.9M 01 Apr 2010 31 Mar 2011 10-K 16 Jul 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.